Clinical Research, Amyotrophic Lateral Sclerosis (ALS)
Who We Are
Gladstone Institutes was founded in 1979 from an endowment from J. David Gladstone. Originally dedicated only to cardiovascular research, Gladstone has broadened its research areas based on emerging trends in global health and technology.
Currently, Gladstone is home to five major institutes, each representing different yet interconnected areas of focus which included Virology, Genomic Immunology, Neurological Disease, Cardiovascular Disease, and Data Science and Biotechnology. Investigators have the freedom to follow their research wherever it leads and work closely with their colleagues in all institutes to deeply probe important questions in biomedicine. They champion highly interactive, creative, and innovative approaches to science as they seek prevention, treatments, and cures for major diseases such as Amyotrophic Lateral Sclerosis (ALS).